Electronic nicotine delivery systems: Executive summary of a policy position paper from the American College of Physicians

Ryan A. Crowley, Thomas Gerald Tape, Douglas M. De Long, Sue S. Bornstein, James F. Bush, Gregory A. Hood, Gregory C. Kane, Robert M. Lohr, Kenneth E. Olive, Shakaib U. Rehman, Micah Beachy, Tracey Henry, Ashley Minaei

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.

Original languageEnglish (US)
Pages (from-to)583-584
Number of pages2
JournalAnnals of internal medicine
Volume162
Issue number8
DOIs
Publication statusPublished - Apr 21 2015

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine

Cite this